CN104507959A - 链格孢属肽类 - Google Patents

链格孢属肽类 Download PDF

Info

Publication number
CN104507959A
CN104507959A CN201380040582.XA CN201380040582A CN104507959A CN 104507959 A CN104507959 A CN 104507959A CN 201380040582 A CN201380040582 A CN 201380040582A CN 104507959 A CN104507959 A CN 104507959A
Authority
CN
China
Prior art keywords
polypeptide
amino acid
seq
salt
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380040582.XA
Other languages
English (en)
Chinese (zh)
Inventor
罗德里克·彼得·哈夫纳
保罗·莱德勒
帕斯卡·希基
马克·拉尔什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niox Healthcare Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46582267&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104507959(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of CN104507959A publication Critical patent/CN104507959A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Ecology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
CN201380040582.XA 2012-06-01 2013-05-30 链格孢属肽类 Pending CN104507959A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1209868.7A GB201209868D0 (en) 2012-06-01 2012-06-01 Alternaria peptides
GB1209868.7 2012-06-01
PCT/GB2013/051439 WO2013179043A1 (en) 2012-06-01 2013-05-30 Alternaria peptides

Publications (1)

Publication Number Publication Date
CN104507959A true CN104507959A (zh) 2015-04-08

Family

ID=46582267

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380040582.XA Pending CN104507959A (zh) 2012-06-01 2013-05-30 链格孢属肽类

Country Status (17)

Country Link
US (1) US20150098969A1 (https=)
EP (1) EP2855515A1 (https=)
JP (1) JP2015520771A (https=)
KR (1) KR20150028788A (https=)
CN (1) CN104507959A (https=)
AU (1) AU2013269326A1 (https=)
BR (1) BR112014029856A2 (https=)
CA (1) CA2875130A1 (https=)
CL (1) CL2014003290A1 (https=)
EA (1) EA201492268A1 (https=)
GB (2) GB201209868D0 (https=)
HK (1) HK1201752A1 (https=)
IL (1) IL235840A0 (https=)
IN (1) IN2014DN10558A (https=)
MX (1) MX2014014461A (https=)
SG (1) SG11201407975TA (https=)
WO (1) WO2013179043A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195382A1 (en) * 2013-06-05 2014-12-11 Alergenetica Sl T cell epitopes derived from alt a 1 or alt a 5 for the treatment of alternaria alternata allergy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022154A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with multiple epitopes
CN101466738A (zh) * 2006-06-09 2009-06-24 碧欧美公司 疫苗载体
WO2012038540A2 (en) * 2010-09-24 2012-03-29 Alergenetica Sl Peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400723B (de) * 1993-08-27 1996-03-25 Biomay Prod & Handel Rekombinante alternaria alternata allergene
JP2007176953A (ja) * 1996-03-10 2007-07-12 Meiji Milk Prod Co Ltd アレルギー疾患に対するペプチド免疫療法剤
JP2003116556A (ja) * 2001-10-09 2003-04-22 Nippon Zenyaku Kogyo Kk アレルギー性皮膚炎治療剤
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101466738A (zh) * 2006-06-09 2009-06-24 碧欧美公司 疫苗载体
WO2009022154A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with multiple epitopes
WO2012038540A2 (en) * 2010-09-24 2012-03-29 Alergenetica Sl Peptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CRAMERI R, RHYNER C.: "NOVEL VACCINES AND ADJUVANTS", 《CURR OPIN IMMUNOL.》 *
喻海琼: "杂色曲霉菌变应原分离、鉴定及纯化", 《中国公共卫生》 *

Also Published As

Publication number Publication date
US20150098969A1 (en) 2015-04-09
AU2013269326A1 (en) 2014-12-18
EA201492268A1 (ru) 2015-05-29
MX2014014461A (es) 2015-02-10
CL2014003290A1 (es) 2015-05-22
IL235840A0 (en) 2015-01-29
BR112014029856A2 (pt) 2017-07-25
KR20150028788A (ko) 2015-03-16
IN2014DN10558A (https=) 2015-08-21
GB201209868D0 (en) 2012-07-18
EP2855515A1 (en) 2015-04-08
JP2015520771A (ja) 2015-07-23
HK1201752A1 (en) 2015-09-11
SG11201407975TA (en) 2015-01-29
WO2013179043A1 (en) 2013-12-05
GB2517871A (en) 2015-03-04
CA2875130A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
EP2428222B1 (en) Vaccine peptide combinations against cat allergy
CN102762225B (zh) 用于针对桦树过敏的疫苗的肽
CN102170897B (zh) 用于治疗豚草变态反应的包含Amb a 1肽的疫苗
CN101820907A (zh) 针对过敏原去敏化的肽
DK2393830T3 (en) Grass peptides for vaccine
JP4347418B2 (ja) 特異的免疫療法のためのイネ科花粉アレルゲン変異体及びそれらの製造及び使用
JPWO1997047648A1 (ja) Ｔ細胞エピトープペプチド
US9850281B2 (en) Cladosporium peptides
CN104507959A (zh) 链格孢属肽类
WO2009095646A2 (en) Peptides from factor viii
EP1015484A1 (en) Peptides derived from complement peptide c3a sequence and antiallergic compositions comprising them
WO2014001820A1 (en) Japanese cedar peptide for preventing or treating allergy
WO2017134430A1 (en) Japanese pollen allergen peptides for preventing or treating allergy
ES2353362T3 (es) Péptidos para insensibilización contra alergenos.
JP2003002897A (ja) ペプチドおよびその用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150408

WD01 Invention patent application deemed withdrawn after publication